Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ballard

Showing results (591-600 of 599) with videos related to

Pageof 60
Sort By:
You have reached the last page of results.This site can display upto 599 results.
Blood Advances|December 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokinesGuido Ghilardi, Luca Paruzzo, Jakub Svoboda, et al.
Nature|July 15, 2021
Highly accurate protein structure prediction with AlphaFoldJohn Jumper, Richard Evans, Alexander Pritzel, et al.
Nature|July 22, 2021
Highly accurate protein structure prediction for the human proteomeKathryn Tunyasuvunakool, Jonas Adler, Zachary Wu, et al.
Nature Immunology|June 3, 2024
The BTLA-HVEM axis restricts CAR T cell efficacy in cancerPuneeth Guruprasad, Alberto Carturan, Yunlin Zhang, et al.
Nature|May 8, 2024
Accurate structure prediction of biomolecular interactions with AlphaFold 3Josh Abramson, Jonas Adler, Jack Dunger, et al.
Blood Advances|March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphomaReid W Merryman, Robert A Redd, Taiga Nishihori, et al.
Science Immunology|July 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P Patel, Guido Ghilardi, Yunlin Zhang, et al.
Leukemia|March 4, 2021
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphomaReid W Merryman, Luca Castagna, Laura Giordano, et al.
Human Mutation|June 12, 2014
Toward male individualization with rapidly mutating y-chromosomal short tandem repeatsKaye N Ballantyne, Arwin Ralf, Rachid Aboukhalid, et al.
Pageof 60

Showing results (591-600 of 599) with videos related to

Sort By:
Pageof 60
You have reached the last page of results.This site can display upto 599 results.
Blood Advances|December 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokinesGuido Ghilardi, Luca Paruzzo, Jakub Svoboda, et al.
Nature|July 15, 2021
Highly accurate protein structure prediction with AlphaFoldJohn Jumper, Richard Evans, Alexander Pritzel, et al.
Nature|July 22, 2021
Highly accurate protein structure prediction for the human proteomeKathryn Tunyasuvunakool, Jonas Adler, Zachary Wu, et al.
Nature Immunology|June 3, 2024
The BTLA-HVEM axis restricts CAR T cell efficacy in cancerPuneeth Guruprasad, Alberto Carturan, Yunlin Zhang, et al.
Nature|May 8, 2024
Accurate structure prediction of biomolecular interactions with AlphaFold 3Josh Abramson, Jonas Adler, Jack Dunger, et al.
Blood Advances|March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphomaReid W Merryman, Robert A Redd, Taiga Nishihori, et al.
Science Immunology|July 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P Patel, Guido Ghilardi, Yunlin Zhang, et al.
Leukemia|March 4, 2021
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphomaReid W Merryman, Luca Castagna, Laura Giordano, et al.
Human Mutation|June 12, 2014
Toward male individualization with rapidly mutating y-chromosomal short tandem repeatsKaye N Ballantyne, Arwin Ralf, Rachid Aboukhalid, et al.
Pageof 60